Waters Corporation (NYSE:WAT) Director Thomas P. Salice sold 3,500 shares of the firm’s stock in a transaction on Monday, November 20th. The shares were sold at an average price of $200.03, for a total transaction of $700,105.00. Following the transaction, the director now directly owns 20,349 shares of the company’s stock, valued at approximately $4,070,410.47. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Shares of Waters Corporation (WAT) opened at $196.57 on Thursday. The company has a quick ratio of 5.71, a current ratio of 6.16 and a debt-to-equity ratio of 0.66. The company has a market cap of $15,752.31, a price-to-earnings ratio of 27.51, a price-to-earnings-growth ratio of 2.87 and a beta of 0.83. Waters Corporation has a twelve month low of $133.35 and a twelve month high of $200.71.

Waters Corporation (NYSE:WAT) last posted its quarterly earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 EPS for the quarter, topping analysts’ consensus estimates of $1.74 by $0.03. The business had revenue of $565.58 million during the quarter, compared to analysts’ expectations of $555.25 million. Waters Corporation had a net margin of 24.34% and a return on equity of 23.61%. The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period last year, the company posted $1.57 earnings per share. equities analysts predict that Waters Corporation will post 7.42 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Thomas P. Salice Sells 3,500 Shares of Waters Corporation (WAT) Stock” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international copyright & trademark laws. The original version of this piece can be read at https://www.thecerbatgem.com/2017/11/23/thomas-p-salice-sells-3500-shares-of-waters-corporation-wat-stock.html.

Several research firms have recently issued reports on WAT. Goldman Sachs Group, Inc. (The) began coverage on shares of Waters Corporation in a research note on Tuesday, September 26th. They set a “hold” rating and a $180.00 price target for the company. Barclays PLC raised their price target on shares of Waters Corporation from $188.00 to $193.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 25th. Zacks Investment Research raised shares of Waters Corporation from a “hold” rating to a “buy” rating and set a $211.00 price target for the company in a research note on Monday, October 23rd. BidaskClub raised shares of Waters Corporation from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, August 16th. Finally, Morgan Stanley reaffirmed an “underweight” rating and set a $192.00 price target (up previously from $183.00) on shares of Waters Corporation in a research note on Friday, October 6th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Waters Corporation currently has an average rating of “Hold” and an average target price of $193.62.

Large investors have recently bought and sold shares of the business. Oppenheimer Asset Management Inc. grew its holdings in Waters Corporation by 0.4% in the second quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock worth $105,000 after purchasing an additional 2 shares during the period. ETF Managers Group LLC acquired a new stake in Waters Corporation in the second quarter worth $106,000. Intellectus Partners LLC grew its holdings in Waters Corporation by 4.9% in the second quarter. Intellectus Partners LLC now owns 667 shares of the medical instruments supplier’s stock worth $123,000 after purchasing an additional 31 shares during the period. First Manhattan Co. acquired a new stake in Waters Corporation in the second quarter worth $130,000. Finally, Edmond DE Rothschild Holding S.A. acquired a new stake in Waters Corporation in the second quarter worth $160,000. Institutional investors and hedge funds own 92.04% of the company’s stock.

About Waters Corporation

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Insider Buying and Selling by Quarter for Waters Corporation (NYSE:WAT)

Receive News & Stock Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related stocks with our FREE daily email newsletter.